Lepermislibre | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
Lepermislibre

BRIEF

published on 07/03/2024 at 18:10, 4 months 17 days ago

Lepermislibre: Monthly Information on the Number of Shares and Voting Rights

Share Capital Voting Rights Euronext Actions Free License
BRIEF

published on 07/03/2024 at 18:10, 4 months 17 days ago

Half-yearly review of the Lepermislibre Liquidity Contract

Liquidity Contract Transactions Actions Free License Half-yearly Review
BRIEF

published on 06/04/2024 at 18:10, 5 months 16 days ago

Lepermislibre: Monthly information on shares and voting rights

Share Capital Voting Rights Actions 2024 Free License
BRIEF

published on 05/07/2024 at 18:10, 6 months 13 days ago

Lepermislibre announces its key share and voting rights figures for April 2024

Financial Information Share Capital Voting Rights Actions Free License
BRIEF

published on 04/10/2024 at 18:10, 7 months 10 days ago

Lepermislibre announces its turnover for the first quarter of 2024

Turnover Financial Strategy Training Free License CPF
PRESS RELEASE

published on 04/10/2024 at 18:05, 7 months 10 days ago

Revenue for the first quarter of 2024
Lepermislibre reports 11% decrease in revenue for Q1 2024 due to challenges in CPF training, but sees growth in traditional offerings. CEO highlights adaptability to market changes

Revenue Market Challenges LePERMISLIBRE Q1 2024 CPF Training
BRIEF

published on 04/04/2024 at 18:05, 7 months 16 days ago

Lepermislibre announces its number of shares and voting rights for March 2024

Share Capital Voting Rights Actions March 2024 Free License
BRIEF

published on 03/27/2024 at 18:05, 7 months 24 days ago

LePERMISLIBRE Reports Positive 2023 Financial Outcomes with Key Growth Indicators

Revenue Growth Operational Excellence LePERMISLIBRE Annual Financial Results Innovative Services
PRESS RELEASE

published on 03/27/2024 at 18:00, 7 months 24 days ago

lePERMISLIBRE announces its 2023 annual results
lePERMISLIBRE announces its 2023 annual results with +13% revenue growth, reduced operating loss, and new innovations. Lyon, March 27, 2024 - lePERMISLIBRE, a pioneer in online driving school in France, published its audited 2023 results

Revenue Growth LePERMISLIBRE Innovations 2023 Annual Results Operating Loss Reduction
PRESS RELEASE

published on 01/24/2024 at 17:45, 9 months 27 days ago

Le permis libre: 2023: Organic sales growth of +13 % 2024: Targeting operating profitability with continued growth
LePERMISLIBRE, the pioneer of online driving school in France, reported a 13% increase in organic sales growth in 2023. Despite a temporary slowdown in Q4, the company is targeting operating profitability in 2024 through gross margin increase and cost reduction. The company also aims to expand its geographic coverage, enhance its service offerings, and develop personalized monitoring of learners' progress in 2024. For more information, visit www.lepermislibre.fr.

LePERMISLIBRE Online Driving School Organic Sales Growth Operating Profitability Geographic Coverage

Accesswire

Published on 11/21/2024 at 14:00, 10 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 13:30, 40 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 40 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 10 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:00, 10 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 55 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 35 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 55 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 2 hours 3 minutes ago

IVU AG publishes Quarterly Report Q3-2024

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 12 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 50 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 25 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE